Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cerebrospinal fluid
Show results for
Products
Services

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This month
  • This Year
  • Older

Cerebrospinal Fluid Articles & Analysis

37 news found

Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants

Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...

ByHemostemix Inc.


Advanced Instruments to acquire and merge with Nova Biomedical

Advanced Instruments to acquire and merge with Nova Biomedical

Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology ...

ByAdvanced Instruments


Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

(“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems, is pleased to announce the successful first implant of the Company’s FDA-cleared ReFlow™ Mini Flusher device in tandem with a “sonolucent” cranial plate ...

ByAnuncia Medical, Inc.


How ReFlow Helped Get Zachary’s Hydrocephalus Under Control and Travel Across the Globe

How ReFlow Helped Get Zachary’s Hydrocephalus Under Control and Travel Across the Globe

Even before Zachary was born nearly 11 years ago, his parents Sherry and Jason knew that he was going to be a special boy – and a wonderful sibling to a twin sister! Zachary was born with spina bifida and hydrocephalus, both of which were diagnosed while in utero. As with many children in the hydrocephalus community, most parents have never heard of the condition, nor understand how it ...

ByAnuncia Medical, Inc.


Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus

Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus

Surgeons at Intermountain Primary Children’s Hospital are the first in the nation to successfully implant a new brain shunt accessory for young patients with hydrocephalus, a neurological condition that causes a buildup of cerebrospinal fluid in the deep cavities of the brain that often causes frequent hospitalizations. This extra fluid ...

ByAnuncia Medical, Inc.


Anuncia Releases User Guide Video for the ReFlow Mini Flusher

Anuncia Releases User Guide Video for the ReFlow Mini Flusher

When the flusher dome is pressed, it will send a small, controlled flush of cerebrospinal (CSF) fluid toward the ventricular catheter. Step 3: Release & Wait (Note: Press, wait 5 seconds) Once the dome has bottomed out, it may be released, allowing it to refill. The flusher dome refills with CSF from the ventricular catheter and fluid ...

ByAnuncia Medical, Inc.


Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

(“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, is pleased to announce the successful first implant of the Company’s FDA-cleared ReFlow™ Mini Flusher device. ...

ByAnuncia Medical, Inc.


7-year-old Boy Managing His Hydrocephalus with ReFlow Ventricular System “Gen 1” Featured on Charleston’s ABC News 4

7-year-old Boy Managing His Hydrocephalus with ReFlow Ventricular System “Gen 1” Featured on Charleston’s ABC News 4

At just 1 pound and 12 ounces, her son, Sutton, arrived with life-threatening health issues, including hydrocephalus - a neurological disorder caused by an abnormal buildup of cerebrospinal fluid in the brain that affects more than one million ...

ByAnuncia Medical, Inc.


Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Based on the unrivaled expertise in developing highly specific diagnostic antibodies for use in sandwich ELISA kits, competitive ELISA kits, and colloidal gold immuno-chromatography strips, Creative Diagnostics has developed diagnostic kits for the quantitative detection of enzymes, proteins, peptides, antibodies, receptors, small molecules, metabolites, and drug derivatives from biological ...

ByCreative Diagnostics


MDA Venture Philanthropy Grant to Support Development of ALS Biomarkers

MDA Venture Philanthropy Grant to Support Development of ALS Biomarkers

” The prognostic test will measure specific protein-based biomarkers in blood and cerebrospinal fluid that indicate the presence of neurodegenerative disease. ...

BynVector


Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Clinical data demonstrating initial safety and efficacy from the RESKUE trial are being presented by Chief Medical Officer Maria Escolar, M.D., at the 29th Congress of European Society of Gene & Cell Therapy (ESGCT), October 11-14, 2022 Subjects treated with FBX-101 have shown increased galactocerebrosidase (GALC) enzyme activity in plasma and cerebrospinal ...

ByForge Biologics, Inc.


Anuncia Medical, Inc., receives FDA clearance for the ReFlow System Mini for the treatment of patients with hydrocephalus

Anuncia Medical, Inc., receives FDA clearance for the ReFlow System Mini for the treatment of patients with hydrocephalus

Food and Drug Administration (FDA) cleared the ReFlow® System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid (CSF) disorders that require shunting. Anuncia Medical announced FDA clearance of ReFlow® System Mini for the treatment of cerebrospinal fluid (CSF) disorders. ...

ByAnuncia Medical, Inc.


LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

An open kerf line can also leave a pathway for the leakage of cerebrospinal fluid ("CSF"), which increases the overall risk of infection. ...

ByRevBio Inc.


Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons

Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons

The SCS is being designed to be a transformative device which prevents obstruction in the cerebrospinal fluid (CSF) catheters implanted in the ventricle of the brain of patients who suffer from hydrocephalus or Normal Pressure Hydrocephalus (NPH). ...

ByMicrobot Medical Inc.


Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme

Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme

Importantly, despite high proportions of differentiated cells, only very low levels of IFNα were detected in plasma or in cerebrospinal fluid, consistent with the Company's expectation that IFNα expression remains tightly regulated outside the tumor sites. ...

ByGenenta Science


Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease

Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease

The article, “A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine,” outlines preliminary evidence suggesting UB-312 is well tolerated and induces dose-dependent antibody production, with high titer levels detectable in cerebrospinal fluid (CSF), a key characteristic for tackling diseases of the ...

ByVaxxinit


Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

” Data to be presented at the ASGCT Annual Meeting include an oral presentation of a study looking at Sangamo’s innovative genetically engineered adeno-associated virus (AAV) capsid platform for delivery to the central nervous system (CNS) after cerebrospinal fluid administration. With protection from the blood-brain barrier, current gene delivery to ...

BySangamo Therapeutics


Fonar Board of Directors Appoints Independent Director

Fonar Board of Directors Appoints Independent Director

FONAR has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. ...

ByFonar Corporation


Fonar Announces First Fiscal Quarter Earnings

Fonar Announces First Fiscal Quarter Earnings

Damadian continued, “FONAR has the only MRI that has the ability to make cines (movies) of the cerebrospinal fluid (CSF) as it flows up and down the neck and around the brain in the upright, weight-loaded position. ...

ByFonar Corporation


Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis

Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis

Finding: Patients Receive More Precise Diagnosis With Blood Test At the Gerontological Society of America (GSA) Annual Meeting, research was shared that involved asking physicians ordering the PrecivityAD™ blood test to evaluate the following for each patient before and after the blood test was given: Likelihood of AD (% estimates); Medication prescribing plan (anti-AD drugs); and ...

ByC2N Diagnostics

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT